Member Info for Jimboooo

Anyway, now queuing to sell the last of my holding, good luck all, I think you'll need it. I won't be posting back here the rampers will be pleased to know.

If something like the bigger news organisations were to get wind of it, the dodgy, half finished, error strewn, publicly accessible website, by a brand new 'partner', promoting another unknown antibody test, claiming false iso accreditation for another new partner, does not look good for Avacta. Makes you wonder how they granted partnerships to a company that didnt exist - family friends with lots of Avacta shares? Tax reasons? Combined with the test being massively delayed and still months away, the Belgium investigation showing that saliva testing doesn't work for symptomatic low viral load individuals (which Avacta must have known about) and it really does not look good.

I'll let's see what motley Fool and financial times think of it and let them do their own investigations.

"AS has resigned."

Chinese manufactured virus. If China had the vaccine it would look too obvious. Give vaccine to Russian allies to release and 'develop', split the profit from Western mugs.

It's what I would do

They release an RNS when the cleaner goes for a dump. The only RNS people care about right now, especially the unfortunate mugs in at over £1.50, is the covid test strip, and not only available in a clinical setting but can also be performed at home by anyone. The cancer ones are years away. They've employed someone who knows what they're doing now, hopefully they'll get the whole company back on track as they seem to have lost their way over last couple of months. On paper an amazing game changing product, but run by morons with zero business sense, and more worried about shareholders rather than releasing a damn product. GM could teach Al a thing or two, get a market leading product out first, then big yourselves up.

I've nearly made 25% on my avacta holding just by trading the news! As long as it stays above a quid I'm happy. Nova is where the big money is right now.

No chance of FDA approval for the spit test, that's still weeks if not months off. Avacta and cytiva haven't even finished developing it yet, let alone had it clinically validated. Even then it will only be for professional use, not for home use which is where the money is.

Let's get something validated to actually manufacture before we get too excited. That's not a given yet.

This share will carry on bring a traders dream for the next 3-4 weeks.

So far it looks like the market doesn't give a **** either about the RNS, it's the minimum expected at this stage.

I said this wouldn't be good enough to get us back to £1.50 and was shouted down as I'm not a cultish ramper, who are no doubt balls deep in at £2.00 from not doing their due diligence properly. Numbers don't lie. Let's hope the test is good enough to pass validation. Still, there will be lots of opportunities for trading over next month.

Been on holiday for a while. I see I've missed **** all. Unlike Avacta who seem to have missed out on everything. I guess a return back to £1 looks on the cards over next few weeks. Thank God for Novacyt. Wonder if all the big holders who were conned in at 150p+ will be looking to sue like Sorrento Therapeutics shareholders...

Has AS resigned yet? I imagine that will add 30p to the SP straight away.

NCYT have the advantage that we design and produce most of our tests, keeping the profit. Avacta will only get a small % of each sale for licencing, the manufacturing partners will take a great big cut. I can see the SP there shooting up on release and crashing back down when profit figures are given. The time for me to get out will be as soon as FDA approval given in October time

Avacta at risk of turning in to a pump and dump. I think they wanted to use covid to prove their affirmers work, I just think it came a year too early and they've been comprehensivley beaten to market by 50 or so firms. I'm sure their tech is great, I just wished they were truthful with us shareholders and admitted they've had major issues getting PCR matching accuracy rather than saying the test will be ready in a couple of weeks, 6 weeks ago. Now it's 'shortly'. Imagine if they've been telling govts and industry that, stringing them along - no wonder so many are now coming to Novacyt, we have a 100% accurate spit test, results in the hour which I'm sure will come down in time, doesn't need a lab and can be done anywhere. I think their problem is trying to do too many things at once rather than get something completed. It's like they have ADHD.

Who knows. I wasn't expecting today's rise after the muted response to the RNS. Maybe the market spent the evening researching and then slapping their forehead.

They drink wine, eat cheese and know how to do a good protest. Why?

Tony - hasn't Wednesday always finished lower than Tuesday on here?

The SP is now at a more sensible point, I imagine we'll drop back down until a sales RNS is released, but as long as we remain in the £3 mark we'll be primed for another increase up to £4.

The Avacta lot are seething that their RNS caused the SP to drop and ours goes up. They'll be even more annoyed when they realise NCYT have released their spit test months before theirs has been approved. I still have a small 5 figure holding in Avacta, contemplating whether to take the near 40% profit and bring it over here, being invested there does give me a good reason to wind up the super rampers though.

If it's wood maybe the next RNS with be a partnership announcement with B&Q?

If you look on LinkedIn there are dozens of nurses, clinical staff for collinsongroup, drop some of them a message and ask what equipment they're using. Perhaps make a fake profile, say you work for primerdesign and send a message to say how are you finding our test instruments :D

The Avacta boys and girls are a bit down today. It's like staring at the Christmas tree when santa has forgotten you.

The two gene test probably unneeded now after France said they'll pay for all PCR testing!

I'm not expect anything explosive on Monday, other than perhaps a pointless 'the test is ready, but we can't sell till it's been approved'. Might give some people on here a semi though, as if it's somehow unexpected. The real news that sends the SP to £5 and beyond will come in 4-8 weeks imo.

Groundhog Day, it's been a decent share to trade last few weeks, buy in 120's range, sell Friday for an easy 10-15% - some people dream of that rate of return after 2 years . Sold a good chunk now at 140, will buy back again Tuesday, and repeat.